
CD103+CD8+ Lymphocytes Characterize the Immune Infiltration in a Case With Pseudoprogression in Squamous NSCLC
Keywords: Lung neoplasm; Immunotherapy; Pseudoprogression; PD-1 inhibitor; CD103;